Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
R01 DK102598
Funder:
National Institute of Diabetes and Digestive and Kidney Diseases
Funded outputs count:
41
Funder award ID:
R01 DK102598
OpenAlex ID:
G2225492
Gαz-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice
2024
·
Rachel J Fenske
, Haley N Wienkes
, et al.
·
Journal of the Endocrine Society
The prostaglandin E2 EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity
2024
·
Joshua C. Neuman
, Austin Reuter
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
3
EP3 signaling is decoupled from the regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance
2023
·
Michael D. Schaid
, Jeffrey M. Harrington
, et al.
·
Islets
·
7
PDF
What the BTBR/J mouse has taught us about diabetes and diabetic complications
2023
·
Mark P. Keller
, Kelly L. Hudkins
, et al.
·
iScience
·
8
Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort
2023
·
Benjamin Wancewicz
, Yanlong Zhu
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
9
PDF
Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation
2022
·
Rachel J. Fenske
, Alicia M. Weeks
, et al.
·
Metabolites
·
17
PDF
Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
2021
·
Karin J. Bosma
, Spencer R. Andrei
, et al.
·
Molecular Metabolism
·
29
PDF
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
2021
·
Jaclyn A. Wisinski
, Austin Reuter
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
9
Human Islet Expression Levels of Prostaglandin E 2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity
2021
·
Nathan A. Truchan
, Rachel J. Fenske
, et al.
·
ACS Pharmacology & Translational Science
·
18
PDF
The influence of intermittent hypoxia, obesity, and diabetes on male genitourinary anatomy and voiding physiology
2021
·
Lisa L. Abler
, Chelsea A. O’Driscoll
, et al.
·
American Journal of Physiology-Renal Physiology
·
10
Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS‐1 (832/3) cell glucose‐stimulated insulin secretion
2021
·
Harpreet K. Sandhu
, Joshua C. Neuman
, et al.
·
Pharmacology Research & Perspectives
·
15
Systemic Metabolic Alterations Correlate with Islet-Level Prostaglandin E2 Production and Signaling Mechanisms That Predict β-Cell Dysfunction in a Mouse Model of Type 2 Diabetes
2021
·
Michael D. Schaid
, Yanlong Zhu
, et al.
·
Metabolites
·
24
PDF
Agonist-independent Gαz activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes
2020
·
Michael D. Schaid
, Cara L. Green
, et al.
·
Journal of Biological Chemistry
·
19
Ultrahigh-Resolution Mass Spectrometry-Based Platform for Plasma Metabolomics Applied to Type 2 Diabetes Research
2020
·
Yanlong Zhu
, Benjamin Wancewicz
, et al.
·
Journal of Proteome Research
·
22
Differential Expression of Ormdl Genes in the Islets of Mice and Humans with Obesity
2020
·
Hugo Lee
, Rachel J. Fenske
, et al.
·
iScience
·
17
PDF
A gene expression network analysis of the pancreatic islets from lean and obese mice identifies complement 1q like-3 secreted protein as a regulator of β-cell function
2019
·
James E. Koltes
, Itika Arora
, et al.
·
Scientific Reports
·
13
PDF
Differential Regulation of β‐cell Function by Tonically‐active and Receptor‐activated Gα z : Implications for β‐cell Compensation and Failure
2019
·
Michael D Schaid
, Jeff Harrington
, et al.
·
The FASEB Journal
Beta‐cell‐specific loss of the inhibitory G protein, Gα z , alters development and pathophysiology of Type 1 Diabetes
2019
·
Rachel Fenske
, Darby Peter
, et al.
·
The FASEB Journal
Increasing the dietary ratio of omega 3:omega 6 polyunsaturated fatty acids positively impacts inflammation and islet outcomes in Type 1 Diabetes
2019
·
Darby Peter
, Rachel Fenske
, et al.
·
The FASEB Journal
Age-Dependent Protection of Insulin Secretion in Diet Induced Obese Mice
2018
·
Elizabeth R. De Leon
, Jacqueline A. Brinkman
, et al.
·
Scientific Reports
·
22
PDF
Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus
2018
·
Rachel J Fenske
, Michelle E Kimple
·
Experimental Biology and Medicine
·
13
Short‐term methionine deprivation improves metabolic health via sexually dimorphic, mTORCI‐independent mechanisms
2018
·
Deyang Yu
, Shany E. Yang
, et al.
·
The FASEB Journal
·
98
Restoration of metabolic health by decreased consumption of branched‐chain amino acids
2017
·
Nicole E. Cummings
, Elizabeth M. Williams
, et al.
·
The Journal of Physiology
·
340
PDF
The EP3 Receptor/Gz Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular Disease
2017
·
Michael D. Schaid
, Jaclyn A. Wisinski
, et al.
·
The AAPS Journal
·
17
Radiomanganese PET Detects Changes in Functional β-Cell Mass in Mouse Models of Diabetes
2017
·
Reinier Hernandez
, Stephen A. Graves
, et al.
·
Diabetes
·
40
Show more works
View as search
Year
Topic